Company intelligence / Profile preview

Trioplus Pharmaceuticals Private Limited

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Commercial

Overview

Trioplus Pharmaceuticals Private Limited manufactures, supplies, and exports raw materials for medicines as well as finished pharmaceutical products. The company has a significant export business to African countries such as Nigeria, Chad, Niger, Mali, and Sierra Leone. No clinical trial or novel drug development activity was identified; the company appears focused on commercial supply of pharmaceuticals rather than R&D-driven innovation.

Therapeutic areas: Other
Modalities: Small molecules (inferred from "Raw Material Of Medicines" and "Pharma Medicine")
Industry: Contract Manufacturing Organization

Drug pipeline

2 assets

paracetamol

Commercial

Indications: Pain, Fever

1 more asset in the full pipeline.

Request access →

Partnerships

Suitelife Pharmaceutical Ltd/Suitelife Pharmaceuticals Ltd (major buyer/export partner)

Beyond the preview

Go deeper on Trioplus Pharmaceuticals Private Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trioplus Pharmaceuticals Private Limited.

Explore the full profile